Supplementary Figure S5 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer Article Swipe

Rohit Thummalapalli , Biagio Ricciuti , Chaitanya Bandlamudi , Daniel M. Muldoon , Hira Rizvi , Arielle Elkrief , Jia Luo , Joao V. Alessi , Federica Pecci , Giuseppe Lamberti , Alessandro Di Federico , Lingzhi Hong , Jianjun Zhang , John V. Heymach , Don L. Gibbons , Andrew J. Plodkowski , Vignesh Ravichandran , Mark T.A. Donoghue , Chad Vanderbilt , Marc Ladanyi , Charles M. Rudin , Mark G. Kris , Gregory J. Riely , Jamie E. Chaft , Matthew D. Hellmann , Natalie I. Vokes , Mark M. Awad , Adam J. Schoenfeld · YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.27033031 · OA: W4402818599